| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
9,018 |
8,145 |
$2.56M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
19,886 |
18,755 |
$1.55M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,265 |
7,255 |
$1.54M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,224 |
7,349 |
$1.23M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,548 |
1,401 |
$155K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,147 |
1,111 |
$138K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,244 |
1,084 |
$104K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
799 |
778 |
$102K |
| 36415 |
Collection of venous blood by venipuncture |
8,434 |
7,611 |
$56K |
| 80053 |
Comprehensive metabolic panel |
8,292 |
7,530 |
$50K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,909 |
1,834 |
$33K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,427 |
1,290 |
$29K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
280 |
269 |
$23K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
509 |
497 |
$21K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,471 |
14,012 |
$18K |
| 71046 |
Radiologic examination, chest; 2 views |
343 |
322 |
$13K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
256 |
239 |
$12K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
108 |
103 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
625 |
553 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,128 |
1,096 |
$10K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
117 |
112 |
$8K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
152 |
152 |
$6K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
96 |
95 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
111 |
68 |
$3K |
| 94060 |
|
12 |
12 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
93 |
93 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
41 |
24 |
$2K |
| 83690 |
|
693 |
647 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
233 |
212 |
$1K |
| 87081 |
|
1,103 |
1,010 |
$1K |
| 94726 |
|
12 |
12 |
$1K |
| 84484 |
|
184 |
147 |
$822.75 |
| 94729 |
|
24 |
24 |
$779.80 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,699 |
2,478 |
$752.88 |
| 81001 |
|
1,402 |
1,309 |
$721.13 |
| 71045 |
Radiologic examination, chest; single view |
13 |
13 |
$551.97 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
897 |
773 |
$546.26 |
| J3490 |
Unclassified drugs |
60 |
56 |
$517.89 |
| J2704 |
Injection, propofol, 10 mg |
490 |
374 |
$373.19 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
682 |
505 |
$246.19 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
34 |
31 |
$132.71 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
229 |
196 |
$115.90 |
| 86140 |
|
64 |
61 |
$99.92 |
| 84703 |
|
15 |
15 |
$91.70 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
198 |
177 |
$89.43 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
18 |
12 |
$31.13 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
63 |
52 |
$20.19 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
563 |
332 |
$16.75 |
| J7050 |
Infusion, normal saline solution, 250 cc |
144 |
130 |
$16.32 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
58 |
54 |
$12.38 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
17 |
15 |
$3.05 |
| 87807 |
|
14 |
14 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
16 |
14 |
$0.00 |
| 81025 |
|
29 |
25 |
$0.00 |
| 85610 |
|
12 |
12 |
$0.00 |